Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Caring Brands, Inc. appointed Brian R. Meadows as Chief Financial Officer and principal financial officer, effective September 18, 2026, succeeding Brian John who resigned as Interim CFO and Chairman. Dr. Glynn Wilson, the current CEO, was appointed as the new Chairman of the Board. Mr. Meadows will provide services through a consulting agreement with Myall Luna Ventures Inc., which was amended to increase the monthly fee from $10,000 to $15,000.
Mr. Amihay Hadad has stepped down as Co-Chief Executive Officer of Quantum X Labs Inc., effective September 22, 2026. Consequently, Mr. Yakov Baranes, who previously served as Co-CEO, has been appointed as the company's sole Chief Executive Officer.
Black Hawk Acquisition Corporation has deposited $150,000 into its trust account to extend the deadline for completing its initial business combination. The extension moves the deadline by one month, from September 22, 2026, to October 22, 2026.
First Eagle Private Credit Fund declared regular September 2026 distributions of $0.210 per share for both Class I and Class D common shares. The distributions are payable on October 29, 2026, to shareholders of record as of September 30, 2026. The filing also updated the Fund's NAV to $23.74 per share as of August 31, 2026.
Ares Strategic Income Fund declared monthly distributions for September, October, November, and December 2026 for its Class I, S, and D shares. The gross distribution for each month is set at $0.21430 per share, with the September distribution payable on October 23, 2026, to shareholders of record as of September 30, 2026.
Group 1 Automotive $1.25B Debt Financing with Computershare Trust Company, N.A.
Group 1 Automotive completed a private offering of $1.25 billion in senior notes, consisting of $625 million of 6.250% notes due 2032 and $625 million of 6.625% notes due 2035. The company intends to use the net proceeds of approximately $1,236 million to fund its previously announced acquisition of dealership assets from Hennessy Automobile Companies, Inc. and to repay existing credit facility debt.
Medallion Bank, a subsidiary of Medallion Financial Corp., has launched a public offering of additional shares of its Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series G. The bank intends to use the proceeds for general corporate purposes, which may include redeeming its outstanding Series E Preferred Stock.
Vistagen announced preliminary positive data from the open-label extension portion of its PALISADE-4 Phase 3 study of fasedienol for social anxiety disorder. The data showed the nasal spray was well-tolerated over 12 months of as-needed use and demonstrated clinically relevant improvements in social anxiety symptoms on both clinician-administered and patient-reported scales. The company plans to meet with the FDA this quarter to discuss the regulatory path forward for a potential New Drug Application.
The Bank of New York Mellon Corporation filed a Certificate of Elimination to its Restated Certificate of Incorporation to remove all designations related to its Series F Noncumulative Perpetual Preferred Stock. This administrative action follows the full redemption of all outstanding Series F shares on September 20, 2026.
Worthington Enterprises reported fiscal 2027 first quarter results with net sales increasing 13% to $343.9 million and net earnings rising 22% to $42.6 million. The company achieved 7% organic growth and nearly doubled its free cash flow to $54.0 million while also declaring a $0.20 per share quarterly dividend.
Term
Q1 2027
Earnings call
Sep 23, 2026, 8:30 AM ET
“We started fiscal 2027 with solid performance as our teams continued to execute well and deliver for our customers. We generated 7% organic growth, grew adjusted EBITDA by 10% and nearly doubled free cash flow. These results reflect the progress we are making as we continue to optimize and grow Worthington Enterprises.”
LeonaBio announced that Series A Common Warrants issued in a December 2025 private placement have become exercisable as of September 18, 2026. If the warrants are exercised in full for cash at the $6.35 exercise price, the company would receive approximately $146.2 million in additional capital. The warrants remain exercisable until October 19, 2026.
Aldel Financial II Inc. announced that its sponsor and other holders will convert 6,160,713 Class B ordinary shares into Class A ordinary shares on a one-for-one basis effective October 5, 2026. Following the conversion, the company will have 29,868,213 Class A shares and only one Class B share outstanding. The holders waived any rights to funds in the company's trust account regarding these converted shares.
Reborn Coffee received a deficiency notice from Nasdaq on September 16, 2026, for failing to meet the minimum stockholders' equity requirement of $2.5 million, reporting only $735,642 in its latest quarterly filing. The company has until November 2, 2026, to submit a plan to regain compliance, which could lead to a 180-day extension if accepted. Separately, Nasdaq confirmed the company regained compliance regarding its periodic filing requirements after the late 10-Q was submitted.
CoreWeave $4.2B Debt Financing with U.S. Bank Trust Company, National Association
CoreWeave completed an upsized private offering of $4.2 billion in 2.875% Convertible Senior Notes due 2033, which included the full exercise of a $500 million overallotment option. The notes are senior unsecured obligations guaranteed by certain subsidiaries and are convertible into cash, Class A common stock, or a combination thereof at an initial conversion price of approximately $97.85 per share.
KB Home reported Q3 2026 revenues of $1.30 billion, a 20% year-over-year decrease, and diluted EPS of $1.05. The company noted a challenging housing market due to higher mortgage rates but achieved its goal of returning to a predominantly Built to Order business model. During the quarter, the company also repurchased $50.0 million of its common stock.
Term
Q3 2026
Earnings call
Sep 22, 2026, 5:00 PM ET
“We are operating in a housing market that continues to be challenging, with conditions weakening since our June earnings report. Higher mortgage interest rates have further pressured affordability and, together with geopolitical uncertainty and broader economic headwinds, have caused many prospective buyers to be more cautious on purchasing a home.”
Jeffrey Mezger, Executive Chairman
“We also made significant progress and have now achieved our goal of returning to a predominantly Built to Order business, with BTO homes representing nearly three-quarters of our deliveries in the third quarter, which contributed to our sequentially higher housing gross profit margin.”
Robert McGibney, President and Chief Executive Officer
Quoin Pharmaceuticals announced that the FDA has granted Fast Track Designation to its lead asset, QRX003, for the treatment of Peeling Skin Syndrome. This is the first-ever Fast Track Designation granted for this rare genetic skin disease, which currently has no approved treatments. The company expects to initiate a Phase 2/3 clinical study for the indication in the second half of 2026.
Palmer Square Capital BDC Inc. declared a third quarter 2026 supplemental dividend of $0.02 per share. This is in addition to the previously declared base dividend of $0.36 per share, with both scheduled for payment on October 13, 2026, to shareholders of record as of September 25, 2026.
Associated Banc-Corp entered into an employment transition agreement with Randall J. Erickson, who will retire as General Counsel on October 13, 2026. Erickson will serve as an Attorney-Advisor through January 4, 2027, maintaining his current base salary and eligibility for his full 2026 short-term incentive and continued vesting of long-term incentive awards. This agreement formalizes the compensation and transition terms for his departure and advisory period.
Take-Two Interactive Software held its 2026 Annual Meeting of Stockholders where shareholders elected ten directors, approved executive compensation on an advisory basis, and ratified Ernst & Young LLP as auditors. Additionally, stockholders approved a charter amendment to limit the liability of certain officers as permitted by Delaware law.
TriSalus Life Sciences received FDA 510(k) clearance for its TriNav Advance device, an expansion of its Pressure-Enabled Drug Delivery (PEDD) portfolio. The device is designed to access small, distal vessels during liver embolization procedures and the company expects to commence commercialization in the coming weeks.
ProPetro Holding Wins Contract from Targa Resources Corp.
ProPetro's PROPWR business unit entered into long-term contracts to commit approximately 230 megawatts of power generation capacity to a subsidiary of Targa Resources Corp. The behind-the-meter power will support Targa's natural gas processing infrastructure in the Permian Basin, with full deployment expected in early 2028.
Federal Home Loan Bank of Des Moines $2.64B Debt Financing with Office of Finance
The Federal Home Loan Bank of Des Moines committed to issue approximately $2.64 billion in consolidated obligation bonds and notes between September 16 and September 18, 2026. These debt securities include both fixed-rate and variable-rate instruments with maturities ranging from 2027 to 2036. The obligations are joint and several liabilities of the eleven Federal Home Loan Banks used to fund operations and provide liquidity to members.
The United States District Court for the Middle District of Florida issued a post-trial ruling in a trademark infringement case against Beyond Meat regarding its 'Great Taste Plant-Based' tagline. The Court significantly reduced a previous jury award of $23.5 million in actual damages to $37,500, while maintaining a $15.4 million disgorgement of profits, resulting in a total judgment of approximately $15.44 million. The company noted that further appeals or motions may be pursued by either party.
Huckleberry.ai Divestiture to Progress Software Corporation for $221M
Huckleberry.ai, Inc. (formerly Domo, Inc.) completed the sale of substantially all of its assets and employees to Progress Software Corporation for approximately $221 million in cash. Following the divestiture, the company remains a debt-free public entity with over $900 million in net operating loss carryforwards and will trade under the new ticker 'HUCK' starting September 24, 2026.
Endovia Health Sciences $500K Debt Financing with C/M Capital Master Fund, LP
Endovia Health Sciences closed an initial $500,000 tranche of secured convertible debt funding from C/M Capital Master Fund, LP. This financing is part of a larger $1 million commitment intended to accelerate the development and commercialization of CannEpil®, the company's cannabinoid-based pharmaceutical asset.
Star Equity Holdings, Inc. furnished a formal investor presentation deck as of September 22, 2026, detailing its business operations and strategy as a diversified holding company. The presentation highlights the company's focus on creating shareholder value through organic growth, acquisitions, and share repurchases.
Progress Software Signs $400M M&A Deal with Domo, Inc.
Progress Software completed its acquisition of substantially all assets and employees of Domo, Inc.'s AI and data platform business for $400 million in cash. The deal adds over 2,400 customers and strengthens Progress's capabilities in cloud-native AI, data visualization, and governance for enterprise AI initiatives.
GE HealthCare Technologies Inc. has appointed Pascal Desroches, the current CFO of AT&T, to its Board of Directors effective January 4, 2027. Mr. Desroches will also serve on the Audit and Talent, Culture, and Compensation Committees, bringing over 30 years of experience in finance and corporate strategy to the board.
Aytu BioPharma reported fiscal 2026 fourth quarter net revenue of $16.1 million, a 6.4% increase year-over-year, driven by the commercial launch of EXXUA which generated $3.9 million in the quarter. For the full fiscal year 2026, net revenue was $57.6 million with a net loss of $14.3 million, as the company prioritized investments in its EXXUA launch over its legacy ADHD and pediatric portfolios.
Term
FY2026
Earnings call
Sep 22, 2026, 4:30 PM ET
“Although we remain in the early stages of the EXXUA launch, the continued momentum we saw throughout the fourth quarter further reinforces our confidence in this exciting opportunity.”
Sky Quarry Inc. stockholders approved two separate proposals to authorize the Board of Directors to effect reverse stock splits at ratios ranging from 1-for-2 to 1-for-25. The first split can be implemented within two years, and a second split is authorized to occur after the first, also within a two-year window. Stockholders also approved the company's 2026 Omnibus Incentive Plan during the special meeting.